A federal judge is allowing a trio of conservative states to intervene in a lawsuit that could ultimately limit the availability of the abortion medication mifepristone, complicating an ongoing battle over reproductive rights playing out at the US Supreme Court.
US District Court for the Northern District of Texas Judge Matthew Kacsmaryk on Friday ruled that Kansas, Idaho, and Missouri can intervene in conservative physician and medical associations’ lawsuit against the Food and Drug Administration over decisions on mifepristone’s availability to the public.
The lawsuit dates back to late 2022 and has since ping-ponged between the US Court of Appeals ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.